McMaster RARE‐Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome

ISTH Academy, Kimberly Legault, 227420

Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti‐factor IXa/factor X bispecific antibody emicizumab: comment

ISTH Academy, Hideo Wada, 227421

In‐depth comparison of N‐glycosylation of human plasma‐derived factor VIII and different recombinant products: from structure to clinical implications

ISTH Academy, Birgit M. Reipert, 227422

Clinical and economic impact of compression in the acute phase of deep vein thrombosis

ISTH Academy, Elham E. Amin, 227423

Elevated plasma levels of P‐selectin glycoprotein ligand‐1‐positive microvesicles in patients with unprovoked venous thromboembolism

ISTH Academy, John-Bjarne Hansen, 227424

Hemorrhagic disorders of fibrinolysis: a clinical review

ISTH Academy, Joline Lieke Saes, 227425

Reliability of hemostasis biomarkers is affected by time‐dependent intra‐patient variability

ISTH Academy, Sylvie Bouvier, 227426

The fibrinogen prothrombin time‐derived method is not useful in patients anticoagulated with low molecular weight heparins or rivaroxaban

ISTH Academy, Cristina Duboscq, 227427

Pleiotropic effects of the hemostatic system

ISTH Academy, Henri Spronk, 227436

Hollow organosilica beads as reference particles for optical detection of extracellular vesicles

ISTH Academy, Zoltan Varga, 227437

Issue Information

ISTH Academy, Session Speakers, 227438

Reduction in physical function in women after venous thromboembolism

ISTH Academy, Kaitlin A Hagan, 227439

An international collaborative study to compare different von Willebrand factor glycoprotein Ib binding activity assays: the COMPASS‐VWF study

ISTH Academy, Imre Bodó, 227440

Carboxypeptidase B2 and carboxypeptidase N in the crosstalk between coagulation, thrombosis, inflammation, and innate immunity

ISTH Academy, John Morser, 227441

What the neighbors say

ISTH Academy, Session Speakers, 227442

Immune Thrombocytopenia: Pathophysiology and Treatment: Future Directions

ISTH Academy, Philip Choi, 223617

The Measurement of Mean Platelet Volume in the Differential Diagnosis of ITP: Case Report and State of the Art (Case Based Presentation)

ISTH Academy, Patrizia Noris, 223616

Low Dose DOACs for the Secondary Prevention of VTE (Case Based Presentation)

ISTH Academy, Jeffrey I. Weitz, 223621

Abnormal Bleeding in Mild/Moderate ITP: Case Report and the Role of Platelet Dysfunction (Case Based Presentation)

ISTH Academy, Andrew Frelinger, 223615

DOACs for the Treatment of VTE in Unusual Site VTE (Case Based Presentation)

ISTH Academy, Walter Ageno, 223620

Immune Platelet Disorders (Case Based Presentation)

ISTH Academy, Donald Arnold, 223614

DOACs for the Treatment of Cancer Associated Thrombosis (Case Based Presentation)

ISTH Academy, Marc Carrier, 223619

The Role of Platelets in Vascular Integrity and in the Prevention of Bleeding

ISTH Academy, Michael Berndt, 223613

Unmet Clinical Needs in the Management of Venous Thromboembolism

ISTH Academy, Sabine Eichinger, 223618

Sepsis Reconsidered

ISTH Academy, Clifford S. Deutschman, 223608

Targeting the Contact System for Treatment of Thrombo-Inflammatory Diseases

ISTH Academy, Thomas Renné, 223612

DIC in Sepsis and Obstetrics

ISTH Academy, Beverly Hunt, 223607

Medical Device Thrombosis- Causes and Prevention (Case Based Presentation)

ISTH Academy, Jeffrey I. Weitz, 223611

Sepsis: A Critical Care Physician Perspective

ISTH Academy, Jerry J. Zimmerman, 223606

Hereditary Angioedema - Examining a Complex Etiology (Case Based Presentation)

ISTH Academy, Marcel Levi, 223610

A Hemostasis Perspective on How to Mitigate Sepsis Mortality

ISTH Academy, Toshiaki Iba, 223605

Sepsis a Disorder of Coagulation or Platelets?

ISTH Academy, Dermot Cox, 223604

Resurrection of the Contact System - What We Now Know and What Remains to Be Determined

ISTH Academy, Coen Maas, 223609

Expert Commentary

ISTH Academy, Peter Lenting, 223706

Expert Commentary

ISTH Academy, Steven Pipe, 223707

Closing

ISTH Academy, Guy Young, 223708

Recommendations of the International Council for Standardization in Hematology (ICSH) for Laboratory Measurement of Direct Oral Anticoagulants (DOAC)

ISTH Academy, Robert Gosselin, 223727

The DaXa Inhibition Test: A Concept for a Universal and Easily Available aXa Test That Measures the Direct Inhibitory Effect of All Anti-Xa Drugs

ISTH Academy, Joost van Pelt, 223728

Reversal and Biological Strategies in French GIHP-NACO Registry: Need for Guidance

ISTH Academy, Pierre Albaladejo, 223729

Novel Approaches for Immune Tolerance Induction

ISTH Academy, David Lillicrap, 223698

Extended Half-Life Products and ITI

ISTH Academy, Manuel Carcao, 223699

Prophylaxis with ITI

ISTH Academy, Carmen Escuriola-Ettingshausen, 223700

Debate: ITI in the Era of Emicizumab - Yes

ISTH Academy, Ri Liesner, 223701

Debate: ITI in the Era of Emicizumab - No

ISTH Academy, Beatrice Nolan, 223702

Welcome and Introduction

ISTH Academy, Mark Crowther, 223723

DOACs Measurements and Clinical Events: Recent Evidences from the Literature and the Presentation of the MAS - Measure and See" Study"

ISTH Academy, Sophie Testa, 223724

Calibration of SSC/ISTH Plasma Standard Lot #5

ISTH Academy, Craig Thelwell, 223691

Calibration of WHO International Standard for Factor V

ISTH Academy, Anthony Hubbard, 223692

Hemophilia Carriers Nomenclature

ISTH Academy, Robert Sidonio, 223693

Gene Therapy Clinical Trials

ISTH Academy, Alok Srivastava, 223694

EHC Partners Programme

ISTH Academy, Brian O'Mahony, 223695

Plasminogen Deficiency

ISTH Academy, Charles Nakar, 223696

Diagnosing Rare Platelet Disorders

ISTH Academy, Diane Nugent, 223697

Impact of DOACs on LAC Testing: The Australian Perspective

ISTH Academy, Jennifer Curnow, 223714

Evaluation of the DOAC-Stop® Procedure to Overcome the Effect of DOAC on Several Tests for Thrombophilia Screening

ISTH Academy, Francois Mullier, 223715

Unusual Site Thrombosis Treated with DOACs

ISTH Academy, Nicoletta Riva, 223717

CVT Registry

ISTH Academy, Francesco Dentali, 223718

START Events registry

ISTH Academy, Sophie Testa, 223719

ORTHO-START registry

ISTH Academy, Elvira Grandone, 223720

DOAC Testing in Ontario: Results from IQMH

ISTH Academy, Karen Moffat, 223721

Venous Stent Registry

ISTH Academy, Sam Schulman, 223722

Introduction to SSC Sessions

ISTH Academy, Guy Young, 223684

Top Abstract Presentation: Enhanced FIX Collagen IV Binding Shows Improved Hemostatic Effects in a Hemophilia B Mouse Model

ISTH Academy, Davide Matino, 223685

Treatment of Breakthrough Bleeds

ISTH Academy, Peter Collins, 223686

Laboratory Issues

ISTH Academy, Stefan Tiefenbacher, 223688

Surveillance and Monitoring for Adverse Events

ISTH Academy, Flora Peyvandi, 223689

Institute for Clinical and Economic Review of Emicizumab

ISTH Academy, David Rind, 223690

Welcome and Introduction

ISTH Academy, Mark Crowther, 223709

Top Abstract Presentation: Outcomes in Non-Valvular Atrial Fibrillation Patients with Good and Poor INR Control After Switching to Direct Oral Anticoagulants

ISTH Academy, Scott Kaatz, 223710

Is Laboratory Monitoring of DOAC Required in Patients with APS- Insight from the Canadian RAPS Study

ISTH Academy, Kim Legault, 223713

Novel Approaches to Pharmacokinetics and Individualized Pharmacologic Dosing of Factor Products

ISTH Academy, Peter Collins, 223597

Why It Is Safe to Continue Antithrombotics for Some Procedures and Not Others?

ISTH Academy, Peter Verhamme, 223603

Using Electronic Data to Manage Hemophilia

ISTH Academy, Niamh O'Connell, 223596

Perioperative Prevention of Thromboembolism: An Asian Perspective

ISTH Academy, Heng Joo Ng, 223602

Hemophilia A With Inhibitors (Case Based Presentation)

ISTH Academy, Carmen Escuriola-Ettingshausen, 223595

Determinants of Bleeding in a Perioperative Setting (Case Based Presentation)

ISTH Academy, Charles Marc Samama, 223601

Hemophilia B (Case Based Presentation)

ISTH Academy, Johnny Mahlangu, 223594

Determinants of Acute Coronary Syndromes in a Perioperative Setting

ISTH Academy, Ursula Rauch-Kröhnert, 223600

Hemophilia A (Case Based Presentation)

ISTH Academy, Beatrice Nolan, 223593

The Role for Laboratory Testing Before Urgent Surgery (Case Based Presentation)

ISTH Academy, Adam Cuker, 223599

The History of Hemophilia Replacement Therapy: From Samuel Lane to Extended Half-Life Factor Replacement Therapy

ISTH Academy, Kathelijn Fischer, 223592

Perioperative Mechanisms of Thrombosis

ISTH Academy, John-Bjarne Hansen, 223598

Thrombin Generation and Adverse Pregnancy Outcomes

ISTH Academy, Irina Gribkova, 213446

Cost-effectiveness of Edoxaban versus Dalteparin for Treatment of Cancer-associated Thrombosis

ISTH Academy, Nathan Connell, 213450

From Tissue Factor to Thrombin to Fibrin under Whole Blood Flow: Thrombin Makes Fibrin but Fibrin Quenches Thrombin

ISTH Academy, Scott Diamond, 213473

Generation of Neo-epitopes on Hypochlorous Acid-modified Human Antithrombin: An Immunological Study

ISTH Academy, Parvez Ahmad, 213539

Structural and Functional Study of Naringin Octasulfate (NOS) on Human Antithrombin and Probing its Role in Thrombus Reduction using Rat Model

ISTH Academy, Irshad Ahmad, 213565

Inappropriate Use of Fresh Frozen Plasma in a Tertiary Care Hospital

ISTH Academy, Sidra Asad Ali, 213616

Establishment of a Centralized Monitoring System for Patients Receiving Anticoagulant Therapy in the Arkhangelsk Region Russia

ISTH Academy, Nadezda Vorobyeva, 213637

Arterial Thrombosis Depends on Shear Rate More Than Shear Rate Gradient

ISTH Academy, David Ku, 213655

The Relationship between Neutrophil Lymphocyte Ratio and Deep Vein Thrombosis in Unilateral Limb Edema in Suspected Deep Vein Thrombosis Patients

ISTH Academy, Ikhwan Rinaldi, 213672

Effect of Anti-arrhythmic Medication Drug Interactions on Thrombotic and Bleeding Outcomes in Patients with Atrial Fibrillation

ISTH Academy, Matthew Wanat, 213696

Efficacy and Safety of Rivaroxaban and Apixaban in Relation to Low Molecular Heparin and Vitamin K Antagonists in Acute Venous Thromboembolism - A Single Center Prospective Study

ISTH Academy, Waldemar Wysokinski, 213717

Reproducibility of Rotem® Device

ISTH Academy, Erica Scalambrino, 213800

Assessment of General Awareness of Thrombosis and How Best to Communicate this Information

ISTH Academy, Ann Marie O'Neill, 213868

Comparison of Risk Assessment Methods to Prevent Venous Thromboembolism (VTE) in Surgical Patients with Short Length of Hospital Stay

ISTH Academy, maria chindamo, 213894

miRNA Expression Profile in Venous Thrombosis Disease: Results from the Genetic Analysis of Idiopathic Thrombophilia Project

ISTH Academy, Alba Rodriguez-Rius, 213920

Coagulation Abnormalities and Risk Assessment in Acute Promyelocytic Leukemia - An Experience fom Resource Constraint Country

ISTH Academy, Nida Anwar, 213979

Direct Oral Anticoagulants in Venous Thromboembolic Disease; Boon or Bane?

ISTH Academy, Andrea Ang, 214002

Are IgM Antiphospholipid Antibodies Redundant in the Classification Criteria for the Antiphospholipid Syndrome?

ISTH Academy, Walid Chayoua, 214033